Beyond Air, Inc. Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs
Beyond Air, Inc. (XAIR) had Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs of $27.20 million as of 2025-03-31, per its 10-K filed 2026-06-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts · last filed 2026-06-26
- 2025-03-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $27.20M; Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs as first filed $34.00M.
- 2024-03-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $23.50M.
- 2023-03-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $8.00M.
| Period end | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs as first filed |
|---|---|---|
| 2025-03-31 | $27.20M 10-K · filed 2026-06-26 | $34.00M 10-K · filed 2025-06-20 |
| 2024-03-31 | $23.50M 10-K · filed 2024-06-24 | |
| 2023-03-31 | $8.00M 10-K · filed 2023-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |